We chat with Adam Stoten, the chief operating officer of Oxford University Innovation, about vaccines – not just for covid but also one for tuberculosis he helped develop at a spinout – as well as the importance of the Research Excellence Framework, the Knowledge Exchange Framework and the Knowledge Exchange Concordat, and the success of LAB282. He also exclusively reveals what is next for him personally.
Subscribe
 |
 |
 |
 |
 |
 |
 |
 |
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
